Skip to main content
See every side of every news story
Published • loading... • Updated

Vanderbilt team to test lasso peptides for ovarian cancer

Vanderbilt-Ingram Cancer Center receives a $450,000 grant to develop lasso peptide therapies that enhance immunotherapy response in ovarian cancer.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Scienmag: Latest Science and Health News broke the news on Saturday, November 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal